Previous Page  37 / 48 Next Page
Information
Show Menu
Previous Page 37 / 48 Next Page
Page Background

37

Volume 2 Issue 2

|

S

upporting

Y

our

P

ractice

Opioid analgesic prescribing

for chronic non-cancer

orofacial pain

It is unclear how often Canadian dentists or family

physicians use opioid analgesics for the treatment

of moderate to severe chronic non-cancer orofacial

pain conditions such as temporomandibular

disorders (TMDs) and neuropathies. Dentists, in

particular, may not feel confident prescribing or

monitoring opioid analgesics for these chronic

pain conditions.

There is also little evidence that supports the

use of opioid analgesics for the treatment of

chronic orofacial pain (

Table 1

). Nevertheless,

the use of opioid analgesics for chronic TMDs

pain that has not responded adequately to all

other treatments (i.e., physical therapy, cognitive

and behavioural therapy, NSAIDs such as

ibuprofen or diclofenac, antidepressants such

as nortriptyline or duloxetine, and antiepileptics

such as gabapentin) may be warranted. How­

ever, evidence indicates that only a subgroup

of patients will find opioid analgesics effective

over months or years, and of these, 50% will have

adverse effects that will lead many to discontinue

their use.

8, 9

Thus, it is recommended that initiation

of opioid analgesic therapy be done on a trial

basis and re-evaluated frequently (

Table 1

).

Long-term opioid treatment

of chronic nonmalignant

orofacial pain: unproven

efficacy and neglected safety?

The focus group suggested that future

prospective studies should be conducted to

assess management of acute, post-operative

and chronic orofacial pain in Canada. Such

studies should include quantitative and

qualitative measures of pain as well as measures

of psychosocial factors and addiction risk.

7, 10

These studies should include evaluations at

least 6 months after an operation in order to

determine the prevalence of persistent post-

operative pain and to evaluate the efficacy of

sustained use of opioid analgesics to treat

chronic orofacial pain conditions.

a

References

Complete listofreferencesavailableat

jcda.ca/article/e49

The views expressed are those of the authors and do not necessarily reflect the opinions

or official policies of the Canadian Dental Association.

*Sourceof infographics:CanadianPainSociety.

Pain inCanada factsheet.

June2014.

[accessed2014Dec8].Available

:http://c.ymcdn.com/sites/www.canadianpainsociety.ca/

resource/resmgr/Docs/pain_fact_sheet_en.pdf

The focus group suggested that

future prospective studies should

be conducted to assess management

of acute, post-operative and chronic

orofacial pain in Canada.

1

in

5

Canadian adults

suffer from chronic pain.*

H

Pain accounts for up to

78%

of

visits

to the

emergency department.*

<1%

Less than 1%

of

total CIHR funding and

only 0.25%

of total

funding for health

research goes to

pain research.

(based on 2009 data)

*